Asthma: all 4,012 studies

Page 36 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.

• Study of the Physiology of the Asthma of the Obese Subjects. Breathing Obesity Asthma Study (BOA)CompletedNCT00577733
• An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance MedicationCompletedNCT00577265
• Zileuton and Exhaled Nitric Oxide in AsthmaticsCompletedNCT00575861Phase 4
• The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric PatientsTerminatedNCT00575445
• Pathogenesis and Genetics of Environmental Asthma Ozone StudyCompletedNCT00574158
• Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe AsthmaCompletedNCT00573222
• Early Antiinflammatory Treatment of AsthmaTerminatedNCT00567463Not applicable
• Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in ChildrenCompletedNCT00565955Phase 3
• Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPICompletedNCT00565591Phase 1
• An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaCompletedNCT00563056Phase 3
• Monitoring Asthma Treatment Using Exhaled Nitric OxideCompletedNCT00562991
• The Virtual Asthma ClinicTerminatedNCT00562081Phase 4
• Study of Inhaled Glucocorticosteroid Administration in Asthma PatientsCompletedNCT00559689
• Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate AsthmaCompletedNCT00557700Phase 2
• NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00557297
• Examining the Link Between Obesity, Inflammation, and Response to Asthma MedicationsCompletedNCT00557180
• Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma OutpatientsStatus unknownNCT00557141
• Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With AsthmaCompletedNCT00550797Phase 2
• Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6yearsTerminatedNCT00550758Not applicable
• Clinical Endpoint Trial Investigating Once Daily and Bronchodilator DosingCompletedNCT00549744Phase 2
• A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy VolunteersCompletedNCT00549497Phase 1
• Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)CompletedNCT00546520Phase 3
• Tiotropium for Smoking Asthmatics StudyWithdrawnNCT00546234Phase 4
• Safety and Tolerability of Omalizumab in Patients With Mild to Moderate AsthmaCompletedNCT00546143Phase 4
• Effect of OMT on Asthma Symptoms in Southwest VirginiaCompletedNCT00545376Not applicable
• First Step With Singulair® Therapy (0476-323)CompletedNCT00545324Phase 4
• Leukotriene Receptor Antagonists or Steroids in Pre-School AsthmaCompletedNCT00543686Phase 2
• Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and AsthmaCompletedNCT00542282
• Monitoring Asthma and COPD in Primary CareCompletedNCT00542061Not applicable
• A Long-Term Examination of Asthma From Childhood Through AdolescenceCompletedNCT00541255
• A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)WithdrawnNCT00540839Phase 3
• Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent AsthmaCompletedNCT00536705
• Open-Label Trial of the Use of Minocycline in the Treatment of AsthmaCompletedNCT00536042Phase 2
• Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic AsthmaticsCompletedNCT00535431Phase 2
• A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)CompletedNCT00535028Phase 2
• Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma PatientsCompletedNCT00534625Phase 2
• A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®CompletedNCT00532922
• Characterisation of Asthma in Obese SubjectsCompletedNCT00532831
• Obesity and Asthma:a Specific PhenotypeCompletedNCT00532363
• Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.TerminatedNCT00530166Phase 2
• Effectiveness of a School-Based Hand Sanitizer Program on Reducing Asthma ExacerbationsCompletedNCT00528814Not applicable
• Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled AsthmaCompletedNCT00528723Phase 3
• Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With AsthmaCompletedNCT00526357Phase 2
• Bronchoscopy With Bronchial Biopsies Sub-study of: Persistence of Airway Inflammation and Remodeling in Asthma RemissionWithdrawnNCT00526344
• Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma RemissionCompletedNCT00526019
• Effect of Ciclesonide on Exercise Induced BronchoconstrictionCompletedNCT00525772Phase 3
• Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00524641
• Symbicort SMART (Symbicort Maintenance And Reliever Therapy)CompletedNCT00523679
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
• Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic ChildrenCompletedNCT00522782Phase 4
• Nebulized Magnesium Sulfate in Pediatric AsthmaWithdrawnNCT00522444Phase 3
• Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-PollenCompletedNCT00519740Not applicable
• Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass PollenCompletedNCT00518518Phase 4
• A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.CompletedNCT00517816Phase 1
• Intervention Study to Improve Adherence in AsthmaCompletedNCT00516633Not applicable
• GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled StudyCompletedNCT00515840Phase 3
• Be SMART NIS, Moderate to Servere Asthma Patient ObservationCompletedNCT00514787
• Case Management and Environmental Control in AsthmaCompletedNCT00514436Phase 3
• Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00512954
• A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory AsthmaWithdrawnNCT00512863Phase 2
• Mobile Phone Based Structured InterventionCompletedNCT00512837Not applicable
• A Sequential Dose-Escalation Study in Subjects With Mild AsthmaCompletedNCT00512486Phase 1
• Non Invasive Ventilation in Acute AsthmaStatus unknownNCT00510991Phase 3
• Evaluating the Collaborative Management in Pediatrics (CMP) Training Program Among Pediatric Resident Doctors and Their Patients With Asthma or ObesityCompletedNCT00510341Not applicable
• A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeCompletedNCT00505388
• Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00504062Phase 3
• Comparison of Two Methods of Bronchial Methacholine ProvocationCompletedNCT00503659Not applicable
• A Pharmaceopidemiological Study in Patients Who Use Symbicort SMARTCompletedNCT00503061
• Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum PratenseCompletedNCT00501527Phase 2
• Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With AsthmaStatus unknownNCT00500253Phase 4
• Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma SymptomsCompletedNCT00497523Phase 3
• Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of AsthmaCompletedNCT00497237Phase 3
• Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial AsthmaStatus unknownNCT00496574Phase 4
• Effect of Specific Immunotherapy to Dust Mites in Children With AsthmaStatus unknownNCT00496561Phase 4
• Evaluating the Impact of GP and Practice Nurse Training in Self Regulations Skills on Patient OutcomesCompletedNCT00493090Not applicable
• Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced AsthmaCompletedNCT00492076Phase 4
• Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist PulmonologistTerminatedNCT00491153
• Valuation of Quality of Life in Children With AsthmaCompletedNCT00491101
• Prevention of Asthma and Allergy by Probiotic Lactobacillus GGCompletedNCT00490425Phase 4
• Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With AsthmaCompletedNCT00490243Phase 4
• Does Improving Insulation and Heating Improve Health?CompletedNCT00489762Not applicable
• A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)CompletedNCT00489346Phase 3
• Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With AsthmaCompletedNCT00487773Phase 4
• Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICSTerminatedNCT00486343Phase 4
• Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic AsthmaCompletedNCT00485576Phase 2
• Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male SubjectsCompletedNCT00483899Phase 1
• A Study of MK0359 in Patients With Chronic Asthma (0359-013)CompletedNCT00482898Phase 2
• Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma PatientsCompletedNCT00482508Phase 3
• Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic AsthmaCompletedNCT00482248Phase 3
• Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)CompletedNCT00480649Phase 4
• CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.CompletedNCT00479739Phase 4
• Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent AsthmaCompletedNCT00476268Phase 3
• Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible AsthmaCompletedNCT00476073Phase 3
• Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With AsthmaCompletedNCT00475813Phase 3
• Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)TerminatedNCT00471809Phase 4
• Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in AsthmaCompletedNCT00469989Not applicable
• A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.CompletedNCT00468975Phase 2
• Particulate Reduction Education in City HomesCompletedNCT00466024Phase 3
• Effect of Statins on Asthma Control in Smokers With AsthmaCompletedNCT00463827Phase 2
• A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic PatientsCompletedNCT00463697Phase 1

← Asthma overview